Chris Flexen
SP,RP - Chicago White Sox
Roster %
Eligibility
Chris Flexen took the loss on Monday against the Braves, allowing four runs on six hits across 4 1/3 innings with one strikeout and three walks.
Fantasy Impact
After a pair of scoreless innings to start the game, Atlanta was finally able to get to Flexen. It could have been worse for the veteran in a tough matchup. He is scheduled to face the Royals next.
White Sox GM Chris Getz said he wants Chris Flexen in the rotation to begin the year.
Fantasy Impact
"The idea is for Chris to be a starter for us," Flexen said. "Based on his skill set and the potential of his pitch mix and his experience, we’d love to give him a solid runway as a starter with us.” Dylan Cease, Erick Fedde and Michael Kopech appear to be locks in the rotation for the White Sox with Flexen competing for one of the other two spots.
Chris Flexen is expected to be a part of the White Sox rotation in 2024.
Fantasy Impact
Flexen signed a one-year deal with the White Sox back in late December. The 29-year-old righty has bounced between a starting role and the bullpen while pitching for both the Mariners and Rockies over the last two seasons. However, Flexen posted a nice 3.61 ERA while logging 179 2/3 innings over 31 starts in 2021, which is the type of load the White Sox want from him in 2024.
Chris Flexen has agreed to a one-year, $1.75 million deal with the White Sox.
Fantasy Impact
The deal includes up to $1 million in performance bonuses. Flexen posted a 6.86 ERA last season with the Mariners and Rockies across 29 appearances with 16 starts. He'll try to earn a spot in the starting rotation for the White Sox this year.
Chris Flexen's struggles continued on Tuesday as he allowed nine hits and three earned runs over 5.1 innings pitched against the Rockies.
Fantasy Impact
With a 7.22 ERA and a 1.76 WHIP on the season, Flexen has been a major disappointment for fantasy owners, and this outing did little to inspire confidence in his ability to turn things around. With only one win in 13 starts and a lackluster 6.8 K/9, it's difficult to trust Flexen as a viable fantasy option moving forward.